Blog

Clinical intelligence: Horus ML CEO, Jesús Prada Alonso

Clinical intelligence: Horus ML CEO, Jesús Prada Alonso

In today's rapidly evolving healthcare landscape, the potential of artificial intelligence to improve clinical care has been widely acknowledged – yet its real-world application remains limited. 

Horus ML is changing this paradigm with their groundbreaking approach to cardiovascular health. Through automatic clinical image analysis and early diagnosis tools, they're making sophisticated AI-powered healthcare more accessible, particularly in primary care settings.

Leading this healthcare revolution is Jesús Prada Alonso, co-founder and CEO, whose background spans both artificial intelligence and healthcare innovation. As his startup takes its place among the 4YFN25 finalists, we spoke with Alonso about his vision for the future of AI-enabled healthcare and the challenges of bringing cutting-edge technology to clinical practice.

What are your key goals for Horus ML over the next four years? 

By 2028, we want to reach 100 clients and impact more than 10 million patients. We're targeting a turnover of €3M with an expanded team of 20 members. Most importantly, we aim to increase the detection of asymptomatic atherosclerosis in Spain by at least 40%.

What impact do you aim to achieve with your technology? 

The potential of AI techniques to improve the clinical-care environment has been widely studied, but its real application in clinical practice is still very limited. We think, and hope, that this drastically changes in the coming years, allowing healthcare to be better prepared for future challenges, like population increasing the average age which will lead to a higher percentage of chronic patients, hospital pressure and potential new outbreaks.

What are the main challenges you face? 

There are currently very few examples in Spain of the actual use of AI-based tools in clinical practice. In many cases, what prevents the solutions developed from being used in clinical practice are difficulties in integrating them with the healthcare institution's IT systems. Although the situation has improved in recent years, there is still a cultural barrier in the healthcare sector regarding the adoption of AI, mainly due to lack of knowledge that causes a distrust of these technologies. 

Finally, how will AI transform your sector between now and 2028? 

AI can play a vitally important role in assisting medical specialists in their decisions and is a tool that can have a significant positive impact on healthcare practice in different areas, such as reducing patient mortality, reducing the time required by doctors for certain clinical processes or reducing healthcare costs. We want to place special emphasis on two aspects where AI can have a big impact in the coming years: bringing certain clinical processes to primary care, and improved patient monitoring, with a special focus on chronic pathologies.

To know more about Horus ML visit their site and if you want to discover more about the 4YFN25 awards, check this out: 4yfn.com/4yfn-awards.